[TLX] YoY Annual Result on 31-Dec-2024 [#FY]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
31-Dec-2024
Financial Year
2024
Quarter
31-Dec-2024 [#FY]
Profit Trend
YoY- 857.95%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Annual Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 783,207 502,547 160,096 7,596 5,213 3,485 195 298.19%
PBT 56,056 3,087 -98,622 -99,039 -60,253 -42,815 -15,714 -
Tax 6,137 -2,124 5,457 -18,529 -15,366 -14,948 -1,884 -
NP 49,919 5,211 -104,079 -80,510 -44,887 -27,867 -13,830 -
Tax Rate -10.95% 68.80% - - - - - -
Total Cost 733,288 497,336 264,175 88,106 50,100 31,352 14,025 93.25%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin 6.37 1.04 -65.01 -1,059.90 -861.06 -799.63 -7,087.06 -
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS 0.15 0.02 -0.34 -0.29 -0.17 -0.12 -0.07 -
EPS Diluted 0.14 0.02 -0.34 -0.29 -0.17 -0.12 -0.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.